Loading chat...
US HR955
Resolution
Status
12/17/2025
Primary Sponsor
Jennifer McClellan
Click for details
AI Summary
-
House Resolution recognizing the importance of continued U.S. commitment to ending pediatric HIV/AIDS globally, noting that 1.4 million children and 53% of the 40.8 million people living with HIV worldwide are women and girls (2024 data)
-
Highlights that antiretroviral prophylaxis can reduce mother-to-child HIV transmission to less than 5%, and that PEPFAR has enabled nearly 5.5 million babies to be born HIV-free since inception
-
Notes significant treatment gaps between children and adults: only 55% of children with HIV receive antiretroviral therapy compared to 78% of adults, and 75,000 children died of AIDS-related causes in 2024
-
Supports the Global Alliance to End AIDS in Children by 2030 (established 2022) and its four pillars: closing treatment gaps for pregnant women, preventing new infections, providing accessible testing and care for children, and addressing social/structural barriers
-
Encourages PEPFAR to create a standalone pediatric HIV strategy and reaffirms U.S. commitment to lead global efforts to eliminate pediatric HIV infections and support affected families
Legislative Description
Recognizing the importance of a continued commitment to ending pediatric HIV/AIDS worldwide.
Last Action
Referred to the Committee on Foreign Affairs, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
12/17/2025